Chapter 8. Anticoagulants: Inhibitors of thrombin and factor Xa
- 1 January 2001
- book chapter
- Published by Elsevier
- Vol. 36, 79-88
- https://doi.org/10.1016/s0065-7743(01)36048-7
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- In Vitro and in Vivo Properties of Bicyclic Lactam Inhibitors: A Novel Class of Low Molecular Weight Peptidomimetic Thrombin Inhibitors*Thrombosis Research, 2000
- Selective boron-Containing thrombin inhibitors—X-ray analysis reveals surprising binding modeBioorganic & Medicinal Chemistry, 2000
- New advances in the discovery of thrombin and factor Xa inhibitorsCurrent Opinion in Chemical Biology, 2000
- Recent advances in clinical trials of the direct and indirect selective Factor Xa inhibitorsExpert Opinion on Investigational Drugs, 2000
- New Proline Mimetics: Synthesis of Thrombin Inhibitors Incorporating Cyclopentane- and Cyclopentenedicarboxylic Acid Templates in the P2 Position. Binding Conformation Investigated by X-ray CrystallographyJournal of Medicinal Chemistry, 2000
- Antithrombotic Properties of RWJ-50353, a Potent and Novel Thrombin Inhibitor*Thrombosis Research, 2000
- Structural Basis of the Thrombin Selectivity of a Ligand That Contains the Constrained Arginine Mimic (2S)-2-Amino-(3S)-3-(1-carbamimidoyl- piperidin-3-yl)-propanoic Acid at P1Journal of Medicinal Chemistry, 2000
- Chapter 9. Factor Xa inhibitors: Recent advances in anticoagulant agentsPublished by Elsevier ,2000
- Small, noncovalent serine protease inhibitorsMedicinal Research Reviews, 1999
- Progress in the design of inhibitors of coagulation factor XaDrugs of the Future, 1999